Please login to the form below

24

Revenue 2017

Daiichi Sankyo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.

Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance

Sosei Heptares has developed considerable expertise in GPCRs that has allowed it to attract a string of partners, with Genentech joining Pfizer, AstraZeneca, Allergan, Novartis, and Daiichi-Sankyo, amongst others.

Research charity LifeArc cashes $1.2bn royalty from Keytruda

In March it formed a cancer immunotherapy alliance with CRUK and Ono Pharma, in April it licensed an ion channel drug discovery programme to Daiichi Sankyo, and in early May it

One hit, one miss as FDA panel votes on Daiichi’s cancer drugs

separately gave Daiichi Sankyo some succour by backing pexidartinib for a rare condition called tenosynovial giant cell tumour (TGCT). ... tissues. Daiichi Sankyo acquired the drug when it bought Taiwanese firm Plexxikon for almost $1bn in 2011.

Pfizer’s alliance with Sosei Heptares bears first fruit

Pfizer is just one of Sosei Heptares’ big pharma partners, and the company has also attracted sizeable collaborations with AstraZeneca, Allergan, Novartis, and Daiichi-Sankyo.

AZ’s bet on Daiichi’s rival to Kadcyla pays off

Pivotal phase 2 data backs investment. AstraZeneca has the positive pivotal trial it needed to justify its big investment in Daiichi’s HER2-targeting antibody-drug conjugate DS-8201, a rival ... There are no anti-HER2 therapies currently approved for

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Account Director, Healthcare Communications: Salary TBC

Publications Director, Medical Communications agency, Home Based...: Competitive Salary

Strategic Associate Director Healthcare PR, London: Substantiel package

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Publications Director, Medical Communications agency, Oxford: Competitive Salary

Client Partner, Healthcare Brand Communications, London: Highly competitive package

Publications Director, Medical Communications agency, Cambridge: Competitive Salary

Senior Account Manager, Healthcare Advertising Agency: Salary TBC

Precision paediatrics: Treating patients with CAR-T: Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation: We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2): Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...